Biphenyl

Biphenyl

SCHEMBL6770952

C1CSCCN1.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
SIGMAR1 Q99720 3/20 0.45
HTR2C P28335 2/20 0.43
HTR7 P34969 3/20 0.42
HTR1A P08908 2/20 0.42
USP2 O75604 2/20 0.40
TP53 P04637 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2D6 P10635 2/20 0.40
MAPK1 P28482 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HTR6 P50406 2/20 0.39
HTR2A P28223 1/20 0.39
HTR5A P47898 1/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL27749946 0.86 SIGMAR1 (0.42) ALDH1A1SIGMAR1HTR2CHTR7HTR1A
Biphenyl SCHEMBL27720670 0.84 ALDH1A1 (0.64) ALDH1A1SIGMAR1HTR2CHTR7HTR1A
Biphenyl SCHEMBL8201983 0.81 ALDH1A1 (0.60) ALDH1A1SIGMAR1HTR2CHTR7HTR1A
Biphenyl SCHEMBL27760037 0.78 ALDH1A1 (0.56) ALDH1A1SIGMAR1HTR2CHTR7HTR1A
Phthalic Acid SCHEMBL8319145 0.76 ALDH1A1 (0.56) ALDH1A1SIGMAR1HSD17B10HPGDSMN1; SMN2
Benzoic Acid SCHEMBL28506011 0.76 TSHR (0.56) ALDH1A1SIGMAR1USP2TP53CYP1A2
(Phenylsulfonyl)Benzene SCHEMBL3045644 0.76 HTR6 (0.56) HTR2CHTR7HTR1AHTR6HTR2A
Biphenyl SCHEMBL3453455 0.76 ALDH1A1 (0.53) ALDH1A1SIGMAR1HTR2CHTR7HTR1A
Thiomorpholine SCHEMBL93637 0.74 HIF1A (0.42) ALDH1A1SMN1; SMN2MAPTHIF1A
Thiomorpholine SCHEMBL145846 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6686355-B2 TREATING HEART DISEASE, MULTIPLE SCLEROSIS, ARTHRITIS, ATHEROSCLEROSIS, AND OSTEOPOROSIS; ANTICANCER AGENTS WARNER-LAMBERT COMPANY 2004-02-03 US disclosed
US-20020156074-A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors BARVIAN NICOLE CHANTEL (US) 2002-10-24 US disclosed
EP-1233016-A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors WARNER-LAMBERT COMPANY (US) 2002-08-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156074-A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors MMP3, MMP9, MMP13 ALDH1A1 316/4885SIGMAR1 1439/4885HTR2C 1726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.